Apr 9, 2026 07:01AM Pulse Biosciences names Liane Teplitsky as COO, expands CMO role

Apr 7, 2026 07:48AM Pulse Biosciences enrolls first patients in pivotal atrial fibrillation study

Mar 17, 2026 07:02AM Pulse Biosciences shifts focus to cardiac catheter program after AFib study

Mar 12, 2026 07:01AM Pulse Biosciences enrolls first patients in thyroid cancer study

Feb 20, 2026 06:22AM Pulse Biosciences (PLSE) PT Raised to $30 at Oppenheimer

Feb 19, 2026 04:13PM Pulse Biosciences, Inc. (PLSE) Tops Q4 EPS by 7c

Feb 6, 2026 10:41AM Pulse Biosciences stock rises after positive cardiac catheter study data

Jan 30, 2026 04:53AM Mizuho Starts Pulse Biosciences (PLSE) at Outperform

Dec 18, 2025 07:00AM Pulse Biosciences receives FDA approval for atrial fibrillation study

Dec 9, 2025 07:00AM Pulse Biosciences begins thyroid tumor research with MD Anderson Cancer Center

Oct 24, 2025 07:00AM Pulse Biosciences enrolls first patient in cardiac surgery study

Oct 10, 2025 07:00AM Pulse Biosciences presents cardiac surgical system study results at meeting

Sep 8, 2025 07:02AM Pulse Biosciences gets FDA approval for atrial fibrillation device study

Sep 2, 2025 07:03AM Pulse Biosciences completes first procedures in thyroid nodule study

Aug 26, 2025 07:01AM Pulse Biosciences publishes first-in-human thyroid nodule study data

Aug 15, 2025 10:45AM Pulse Biosciences, Inc. (PLSE) Mentioned as Short Again at White Diamond Research

Aug 12, 2025 04:05PM Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.28

Jul 14, 2025 04:53PM Pulse Biosciences, Inc. (PLSE) Appoints Steven T. Weber as VP of Accounting and Global Corporate Controller

Jul 7, 2025 06:02AM Oppenheimer Starts Pulse Biosciences (PLSE) at Outperform

May 8, 2025 04:44PM Pulse Biosciences, Inc. (PLSE) Reports Q1 Loss of $0.25

Mar 27, 2025 04:09PM Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

Feb 4, 2025 08:01AM Pulse Biosciences, Inc. (PLSE) Appoints Jon Skinner as CFO

Jan 21, 2025 07:01AM Pulse Biosciences (PLSE) Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Jan 10, 2025 08:04AM Pulse Biosciences (PLSE) Appoints Paul LaViolette as Chief Executive Officer

Oct 31, 2024 02:25PM Pulse Biosciences (PLSE) Announces Positive Clinical Data Presented at the American Thyroid Association

Oct 30, 2024 04:13PM Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 3c

Oct 30, 2024 04:03PM Pulse Biosciences, Inc. (PLSE) Appoints David Kenigsberg as Chief Medical Officer of Electrophysiology

Aug 12, 2024 04:02PM Pulse Biosciences (PLSE) Appoints Paul LaViolette to Its Board of Directors

Jul 8, 2024 08:09AM Pulse Biosciences (PLSE) Announces Receipt Of FDA Breakthrough Device Designation For Cellfx® Nspfa Cardiac Surgery System For The Treatment Of Atrial Fibrillation

Jun 28, 2024 08:00AM Pulse Biosciences (PLSE) Announces Preliminary Results for its Rights Offering